11/15/24 18:52 | 11/13/24 | RXRX | Recursion Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gibson Christopher | UT | DO | CEO | S.dm | -302 | 7.55 | 0 | -40 | -5 | 763 | D | | | | | | | | | | | | | | |
10/4/24 18:30 | 10/2/24 | RXRX | Recursion Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gibson Christopher | UT | DO | CEO | S.dm | -245 | 6.12 | 0 | -40 | -5 | 763 | D | | | | | | | | | | | | | | |
9/6/24 16:57 | 9/4/24 | RXRX | Recursion Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gibson Christopher | UT | DO | CEO | S.dm | -244 | 6.09 | 0 | -40 | -5 | 763 | D | | | | | | | | | | | | | | |
8/30/24 16:26 | 8/30/24 | RXRX | Recursion Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gibson Christopher | UT | DO | CEO | M.d | 12 | 2.48 | 0 | 5 | 1 | 763 | D | | | | | | | | | | | | | | |
8/29/24 16:22 | 8/29/24 | RXRX | Recursion Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gibson Christopher | UT | DO | CEO | M.d | 12 | 2.48 | 0 | 5 | 1 | 758 | D | | | | | | | | | | | | | | |
8/28/24 16:12 | 8/28/24 | RXRX | Recursion Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gibson Christopher | UT | DO | CEO | M.d | 12 | 2.48 | 0 | 5 | 1 | 753 | D | | | | | | | | | | | | | | |
8/27/24 16:10 | 8/27/24 | RXRX | Recursion Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gibson Christopher | UT | DO | CEO | M.d | 12 | 2.48 | 0 | 5 | 1 | 748 | D | | | | | | | | | | | | | | |
8/26/24 16:42 | 8/26/24 | RXRX | Recursion Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gibson Christopher | UT | DO | CEO | M.d | 12 | 2.48 | 0 | 5 | 1 | 743 | D | | | | | | | | | | | | | | |
8/23/24 17:25 | 8/23/24 | RXRX | Recursion Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gibson Christopher | UT | DO | CEO | M.d | 12 | 2.48 | 0 | 5 | 1 | 738 | D | | | | | | | | | | | | | | |
8/9/24 16:56 | 8/7/24 | RXRX | Recursion Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gibson Christopher | UT | DO | CEO | S.dm | -343 | 6.86 | 0 | -50 | -6 | 759 | D | | | | | | | | | | | | | | |
7/12/24 18:54 | 7/10/24 | RXRX | Recursion Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gibson Christopher | UT | DO | CEO | S.dm | -748 | 7.48 | 0 | -100 | -12 | 759 | D | | | | | | | | | | | | | | |
6/7/24 16:01 | 6/5/24 | RXRX | Recursion Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gibson Christopher | UT | DO | CEO | S.dm | -871 | 8.71 | 0 | -100 | -12 | 709 | D | | | | | | | | | | | | | | |
5/3/24 18:24 | 5/1/24 | RXRX | Recursion Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gibson Christopher | UT | DO | CEO | S.dm | -810 | 8.10 | 0 | -100 | -11 | 835 | D | | | | | | | | | | | | | | |
4/5/24 17:44 | 4/3/24 | RXRX | Recursion Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gibson Christopher | UT | DO | CEO | S.dm | -1,161 | 8.93 | 0 | -130 | -12 | 939 | M | | | | | | | | | | | | | | |
4/1/24 18:40 | 3/28/24 | RXRX | Recursion Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gibson Christopher | UT | DO | CEO | S.d | -657 | 10.10 | 0 | -65 | -6 | 1,044 | M | | | | | | | | | | | | | | |
3/8/24 19:08 | 3/6/24 | RXRX | Recursion Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gibson Christopher | UT | DO | CEO | S.d | -720 | 11.73 | 0 | -61 | -5 | 1,109 | M | | | | | | | | | | | | | | |
3/8/24 19:08 | 3/6/24 | RXRX | Recursion Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gibson Christopher | UT | DO | CEO | M.d | 176 | 4.42 | 0 | 40 | 4 | 1,109 | M | | | | | | | | | | | | | | |
2/9/24 17:34 | 2/7/24 | RXRX | Recursion Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gibson Christopher | UT | DO | CEO | S.d | -445 | 9.22 | 0 | -48 | -6 | 775 | D | | | | | | | | | | | | | | |
2/9/24 17:34 | 2/7/24 | RXRX | Recursion Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gibson Christopher | UT | DO | CEO | M.d | 78 | 2.48 | 0 | 31 | 4 | 775 | D | | | | | | | | | | | | | | |
1/5/24 20:03 | 1/3/24 | RXRX | Recursion Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gibson Christopher | UT | DO | CEO | S.d | -531 | 9.50 | 0 | -56 | -7 | 792 | M | | | | | | | | | | | | | | |
1/5/24 20:03 | 1/3/24 | RXRX | Recursion Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gibson Christopher | UT | DO | CEO | M.d | 78 | 2.48 | 0 | 31 | 4 | 792 | M | | | | | | | | | | | | | | |
12/8/23 17:22 | 12/6/23 | RXRX | Recursion Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gibson Christopher | UT | DO | CEO | S.d | -448 | 7.49 | 0 | -60 | -7 | 791 | D | | | | | | | | | | | | | | |
12/8/23 17:22 | 12/6/23 | RXRX | Recursion Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gibson Christopher | UT | DO | CEO | M.d | 78 | 2.48 | 0 | 31 | 4 | 791 | D | | | | | | | | | | | | | | |
11/3/23 18:14 | 11/1/23 | RXRX | Recursion Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gibson Christopher | UT | DO | CEO | S.d | -321 | 5.17 | 0 | -62 | -7 | 837 | M | | | | | | | | | | | | | | |
11/3/23 18:14 | 11/1/23 | RXRX | Recursion Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gibson Christopher | UT | DO | CEO | M.d | 78 | 2.48 | 0 | 31 | 4 | 837 | M | | | | | | | | | | | | | | |
10/6/23 18:12 | 10/4/23 | RXRX | Recursion Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gibson Christopher | UT | DO | CEO | S.d | -431 | 7.21 | 0 | -60 | -7 | 843 | D | | | | | | | | | | | | | | |
10/6/23 18:12 | 10/4/23 | RXRX | Recursion Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gibson Christopher | UT | DO | CEO | M.d | 78 | 2.48 | 0 | 31 | 4 | 843 | D | | | | | | | | | | | | | | |
9/8/23 17:01 | 9/6/23 | RXRX | Recursion Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gibson Christopher | UT | DO | CEO | S.d | -517 | 8.81 | 0 | -59 | -6 | 871 | M | | | | | | | | | | | | | | |
9/8/23 17:01 | 9/6/23 | RXRX | Recursion Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gibson Christopher | UT | DO | CEO | M.d | 78 | 2.48 | 0 | 31 | 4 | 871 | M | | | | | | | | | | | | | | |
8/4/23 17:51 | 8/2/23 | RXRX | Recursion Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gibson Christopher | UT | DO | CEO | S.d | -848 | 13.04 | 0 | -65 | -7 | 891 | D | | | | | | | | | | | | | | |
8/4/23 17:51 | 8/2/23 | RXRX | Recursion Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gibson Christopher | UT | DO | CEO | M.d | 176 | 4.42 | 0 | 40 | 5 | 891 | D | | | | | | | | | | | | | | |
7/14/23 18:52 | 7/12/23 | RXRX | Recursion Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gibson Christopher | UT | DO | CEO | M.d | 78 | 2.48 | 0 | 31 | 4 | 916 | M | | | | | | | | | | | | | | |
7/14/23 18:52 | 7/12/23 | RXRX | Recursion Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gibson Christopher | UT | DO | CEO | S.d | -712 | 12.54 | 0 | -57 | -6 | 916 | M | | | | | | | | | | | | | | |
6/9/23 17:12 | 6/7/23 | RXRX | Recursion Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gibson Christopher | UT | DO | CEO | S.d | -511 | 9.05 | 0 | -56 | -6 | 916 | D | | | | | | | | | | | | | | |
6/9/23 17:12 | 6/7/23 | RXRX | Recursion Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gibson Christopher | UT | DO | CEO | M.d | 78 | 2.48 | 0 | 31 | 4 | 916 | D | | | | | | | | | | | | | | |
5/5/23 18:44 | 5/3/23 | RXRX | Recursion Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gibson Christopher | UT | DO | CEO | S.d | -278 | 4.79 | 0 | -58 | -6 | 953 | M | | | | | | | | | | | | | | |
5/5/23 18:44 | 5/3/23 | RXRX | Recursion Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gibson Christopher | UT | DO | CEO | M.d | 78 | 2.48 | 0 | 31 | 3 | 953 | M | | | | | | | | | | | | | | |
4/28/23 16:32 | 1/5/22 | RXRX | Recursion Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gibson Christopher | UT | DO | CEO | S.ad | -137 | 7.39 | 0 | -19 | -3 | 583 | D | | | | | | | | | | | | | | |
4/7/23 17:30 | 4/5/23 | RXRX | Recursion Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gibson Christopher | UT | DO | CEO | S.dm | -352 | 6.60 | 0 | -53 | -6 | 907 | D | | | | | | | | | | | | | | |
4/7/23 17:30 | 4/5/23 | RXRX | Recursion Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gibson Christopher | UT | DO | CEO | M.d | 78 | 2.48 | 0 | 31 | 4 | 907 | D | | | | | | | | | | | | | | |
3/10/23 17:34 | 3/8/23 | RXRX | Recursion Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gibson Christopher | UT | DO | CEO | S.dm | -893 | 8.05 | 0 | -111 | -11 | 939 | M | | | | | | | | | | | | | | |
3/10/23 17:34 | 3/8/23 | RXRX | Recursion Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gibson Christopher | UT | DO | CEO | M.d | 233 | 2.48 | 0 | 94 | 11 | 939 | M | | | | | | | | | | | | | | |
3/6/23 18:07 | 3/2/23 | RXRX | Recursion Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gibson Christopher | UT | DO | CEO | S.d | -166 | 7.92 | 0 | -21 | -2 | 941 | M | | | | | | | | | | | | | | |
2/3/23 17:11 | 2/2/23 | RXRX | Recursion Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gibson Christopher | UT | DO | CEO | S.d | -194 | 9.22 | 0 | -21 | -2 | 942 | M | | | | | | | | | | | | | | |
1/6/23 18:28 | 1/5/23 | RXRX | Recursion Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gibson Christopher | UT | DO | CEO | S.d | -155 | 7.39 | 0 | -21 | -4 | 526 | M | | | | | | | | | | | | | | |
12/2/22 18:17 | 12/1/22 | RXRX | Recursion Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gibson Christopher | UT | DO | CEO | S.d | -359 | 9.04 | 0 | -40 | -6 | 583 | M | | | | | | | | | | | | | | |
12/2/22 18:17 | 12/1/22 | RXRX | Recursion Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gibson Christopher | UT | DO | CEO | M.d | 78 | 2.48 | 0 | 31 | 6 | 583 | M | | | | | | | | | | | | | | |
11/4/22 18:39 | 11/3/22 | RXRX | Recursion Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gibson Christopher | UT | DO | CEO | S.d | -392 | 10.01 | 0 | -39 | -6 | 576 | M | | | | | | | | | | | | | | |
11/4/22 18:39 | 11/3/22 | RXRX | Recursion Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gibson Christopher | UT | DO | CEO | M.d | 78 | 2.48 | 0 | 31 | 6 | 576 | M | | | | | | | | | | | | | | |
10/7/22 19:19 | 10/6/22 | RXRX | Recursion Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gibson Christopher | UT | DO | CEO | S.d | -447 | 11.58 | 0 | -39 | -6 | 563 | M | | | | | | | | | | | | | | |
10/7/22 19:19 | 10/6/22 | RXRX | Recursion Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gibson Christopher | UT | DO | CEO | M.d | 78 | 2.48 | 0 | 31 | 6 | 563 | M | | | | | | | | | | | | | | |
9/2/22 19:24 | 9/1/22 | RXRX | Recursion Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gibson Christopher | UT | DO | CEO | S.d | -404 | 10.35 | 0 | -39 | -7 | 549 | M | | | | | | | | | | | | | | |
9/2/22 19:24 | 9/1/22 | RXRX | Recursion Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gibson Christopher | UT | DO | CEO | M.d | 78 | 2.48 | 0 | 31 | 6 | 549 | M | | | | | | | | | | | | | | |
8/5/22 19:34 | 8/4/22 | RXRX | Recursion Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gibson Christopher | UT | DO | CEO | S.d | -373 | 9.49 | 0 | -39 | -7 | 542 | M | | | | | | | | | | | | | | |
8/5/22 19:34 | 8/4/22 | RXRX | Recursion Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gibson Christopher | UT | DO | CEO | M.d | 78 | 2.48 | 0 | 31 | 6 | 542 | M | | | | | | | | | | | | | | |
7/8/22 18:36 | 7/7/22 | RXRX | Recursion Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gibson Christopher | UT | DO | CEO | S.d | -359 | 9.05 | 0 | -40 | -7 | 529 | M | | | | | | | | | | | | | | |
7/8/22 18:36 | 7/7/22 | RXRX | Recursion Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gibson Christopher | UT | DO | CEO | M.d | 78 | 2.48 | 0 | 31 | 6 | 529 | M | | | | | | | | | | | | | | |
6/6/22 20:54 | 6/2/22 | RXRX | Recursion Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gibson Christopher | UT | DO | CEO | S.d | -258 | 6.11 | 0 | -42 | -8 | 516 | M | | | | | | | | | | | | | | |
6/6/22 20:54 | 6/2/22 | RXRX | Recursion Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gibson Christopher | UT | DO | CEO | M.d | 78 | 2.48 | 0 | 31 | 6 | 516 | M | | | | | | | | | | | | | | |
5/6/22 20:13 | 5/4/22 | RXRX | Recursion Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gibson Christopher | UT | DO | CEO | S.dm | -358 | 6.47 | 0 | -55 | -10 | 512 | M | | | | | | | | | | | | | | |
5/6/22 20:13 | 5/4/22 | RXRX | Recursion Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gibson Christopher | UT | DO | CEO | M.d | 78 | 2.48 | 0 | 31 | 7 | 512 | M | | | | | | | | | | | | | | |
5/2/22 21:30 | 4/28/22 | RXRX | Recursion Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gibson Christopher | UT | DO | CEO | S.dm | -495 | 6.14 | 0 | -81 | -14 | 494 | M | | | | | | | | | | | | | | |
5/2/22 21:30 | 4/28/22 | RXRX | Recursion Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gibson Christopher | UT | DO | CEO | M.dm | 218 | 2.48 | 0 | 88 | 22 | 494 | M | | | | | | | | | | | | | | |
4/25/22 21:26 | 4/21/22 | RXRX | Recursion Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gibson Christopher | UT | DO | CEO | M.dm | 218 | 2.48 | 0 | 88 | 25 | 445 | M | | | | | | | | | | | | | | |
4/25/22 21:26 | 4/21/22 | RXRX | Recursion Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gibson Christopher | UT | DO | CEO | S.dm | -494 | 6.17 | 0 | -80 | -15 | 445 | M | | | | | | | | | | | | | | |
4/20/22 21:03 | 4/18/22 | RXRX | Recursion Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gibson Christopher | UT | DO | CEO | S.d | -262 | 6.83 | 0 | -38 | -9 | 395 | M | | | | | | | | | | | | | | |
4/20/22 21:03 | 4/18/22 | RXRX | Recursion Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gibson Christopher | UT | DO | CEO | M.d | 109 | 2.48 | 0 | 44 | 13 | 395 | M | | | | | | | | | | | | | | |
4/18/22 21:46 | 4/14/22 | RXRX | Recursion Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gibson Christopher | UT | DO | CEO | S.d | -280 | 7.55 | 0 | -37 | -9 | 368 | M | | | | | | | | | | | | | | |
4/18/22 21:46 | 4/14/22 | RXRX | Recursion Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gibson Christopher | UT | DO | CEO | M.d | 109 | 2.48 | 0 | 44 | 14 | 368 | M | | | | | | | | | | | | | | |
4/12/22 20:05 | 4/8/22 | RXRX | Recursion Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gibson Christopher | UT | DO | CEO | S.d | -260 | 6.60 | 0 | -39 | -10 | 340 | M | | | | | | | | | | | | | | |
4/12/22 20:05 | 4/8/22 | RXRX | Recursion Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gibson Christopher | UT | DO | CEO | M.d | 109 | 2.48 | 0 | 44 | 15 | 340 | M | | | | | | | | | | | | | | |
4/11/22 20:54 | 4/7/22 | RXRX | Recursion Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gibson Christopher | UT | DO | CEO | S.d | -257 | 6.54 | 0 | -39 | -11 | 315 | M | | | | | | | | | | | | | | |
4/11/22 20:54 | 4/7/22 | RXRX | Recursion Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gibson Christopher | UT | DO | CEO | M.d | 109 | 2.48 | 0 | 44 | 16 | 315 | M | | | | | | | | | | | | | | |
4/8/22 19:03 | 4/6/22 | RXRX | Recursion Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gibson Christopher | UT | DO | CEO | S.d | -259 | 6.76 | 0 | -38 | -12 | 289 | M | | | | | | | | | | | | | | |
4/8/22 19:03 | 4/6/22 | RXRX | Recursion Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gibson Christopher | UT | DO | CEO | M.d | 109 | 2.48 | 0 | 44 | 18 | 289 | M | | | | | | | | | | | | | | |
4/7/22 21:15 | 4/5/22 | RXRX | Recursion Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gibson Christopher | UT | DO | CEO | S.d | -275 | 7.43 | 0 | -37 | -12 | 262 | M | | | | | | | | | | | | | | |
4/7/22 21:15 | 4/5/22 | RXRX | Recursion Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gibson Christopher | UT | DO | CEO | M.d | 109 | 2.48 | 0 | 44 | 20 | 262 | M | | | | | | | | | | | | | | |
3/15/22 20:57 | 3/11/22 | RXRX | Recursion Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gibson Christopher | UT | DO | CEO | S.dm | -2,177 | 6.48 | 0 | -336 | -59 | 234 | D | | | | | | | | | | | | | | |
3/9/22 20:44 | 3/7/22 | RXRX | Recursion Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gibson Christopher | UT | DO | CEO | S.d | -2,189 | 7.30 | 0 | -300 | -56 | 234 | D | | | | | | | | | | | | | | |
2/24/22 19:24 | 2/22/22 | RXRX | Recursion Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gibson Christopher | UT | DO | CEO | S.d | -1,022 | 10.22 | 0 | -100 | -30 | 234 | D | | | | | | | | | | | | | | |
2/2/22 20:09 | 1/31/22 | RXRX | Recursion Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gibson Christopher | UT | DO | CEO | S.d | -233 | 11.73 | 0 | -20 | -46 | 23 | D | | | | | | | | | | | | | | |
1/14/22 20:42 | 1/13/22 | RXRX | Recursion Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gibson Christopher | UT | DO | CEO | S.dm | -4,692 | 13.76 | 0 | -341 | -94 | 23 | D | | | | | | | | | | | | | | |
12/20/21 17:59 | 12/16/21 | RXRX | Recursion Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gibson Christopher | UT | DO | CEO | S.d | -4 | 20.01 | 0 | 0 | -1 | 23 | D | | | | | | | | | | | | | | |
12/15/21 20:01 | 12/13/21 | RXRX | Recursion Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gibson Christopher | UT | DO | CEO | S.d | -2 | 20.02 | 0 | 0 | 0 | 23 | D | | | | | | | | | | | | | | |
12/10/21 21:42 | 12/8/21 | RXRX | Recursion Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gibson Christopher | UT | DO | CEO | M.d | 71 | 2.47 | 0 | 29 | | 23 | D | | | | | | | | | | | | | | |
12/10/21 21:42 | 12/8/21 | RXRX | Recursion Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gibson Christopher | UT | DO | CEO | S.dm | -237 | 20.13 | 0 | -12 | -33 | 23 | D | | | | | | | | | | | | | | |
12/9/21 21:52 | 12/7/21 | RXRX | Recursion Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gibson Christopher | UT | DO | CEO | S | -405 | 20.48 | 0 | -20 | 0 | 9,448 | M | | | | | | | | | | | | | | |